Candel Therapeutics up on receiving fast track tag from FDA

Candel Therapeutics

13/02/2024 13:44

** Candel Therapeutics shares  CADL.O  jump 8.6% to $1.51
before the bell
    ** Drug developer says US FDA grants fast track designation
for its experimental therapy to improve overall survival in
patients with a type of brain tumor
    ** Co expects to report additional data from its early-sage
study of the therapy in the second half of 2024
     ** Fast track designation facilitate the development and
expedite the review of medicines with the potential to treat
serious conditions and fulfill an unmet medical need
    ** Up to Monday's close, stock had fallen ~32% in past 12
months

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))